Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2003
06/05/2003US20030103978 Antibodies and antigen binding domains used to prevent or treat conditions relating to loss of bone mass and bone disorders; nucleic acid encoding antibodies and antigen binding domains
06/05/2003US20030103976 Anti-fas antibodies
06/05/2003US20030103973 Method for reducing tumor growth with VEGF antagonists combined with radiation and chemotherapy
06/05/2003US20030103972 Identification and characterization of multiple splice variants of the mu-opioid receptor gene
06/05/2003US20030103967 Administering an immunomodulator comprising at least one Fc receptor ligand for treating immune disorders such as allergies, transplanted tissue rejection and autoimmune disorders lupus, rheumatoid arthritis and multiple sclerosis
06/05/2003US20030103964 Methods for designing molecular conjugates and compositions thereof
06/05/2003US20030103948 Streptavidin expressed gene fusions and methods of use thereof
06/05/2003US20030103946 Immunotherapeutic methods and molecules
06/05/2003US20030103945 Methods and compositions for stimulating axon regeneration and preventing neuronal cell degeneration
06/05/2003US20030103943 Multiple site delivery of adenoviral vector for the induction of angiogenesis
06/05/2003US20030103942 Comprises recombinant adeno-associated virus vectors encoding TNF antagonist; antiinflammatory agents for connective tissues and joints
06/05/2003US20030103937 Comprises interleukins for enhancing engraphment of bone marrow during transplantation; for treating allergies and blood disorders
06/05/2003US20030103936 Method of ex-vivo expansion of hematopoeitic cells using interleukin-3 (IL-3) multiple mutation polypeptides
06/05/2003US20030103935 For immunotherapy and detection of gene expression; cancer diagnosis
06/05/2003US20030103903 Detecting nut allergy
06/05/2003CA2852277A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2812024A1 Methods for ligand discovery
06/05/2003CA2486924A1 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization
06/05/2003CA2468878A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their productionor generation
06/05/2003CA2468874A1 Method to isolate genes involved in aging
06/05/2003CA2468838A1 Methods of using improved polymerases
06/05/2003CA2468832A1 Method for producing a recombinant polypeptide
06/05/2003CA2468718A1 Fusion proteins containing tlp peptides
06/05/2003CA2468408A1 Human cdnas and proteins and uses thereof
06/05/2003CA2468353A1 A novel homeobox gene
06/05/2003CA2468326A1 Protein-protein interactions in human immunodeficiency virus
06/05/2003CA2468316A1 Novel compositions and methods for cancer
06/05/2003CA2468240A1 Muscle transcription factors
06/05/2003CA2468230A1 Glycopeptide remodeling using amidases
06/05/2003CA2468187A1 Peptides with growth inhibitory action
06/05/2003CA2468131A1 Disruption of the prostaglandin e synthase 2 gene
06/05/2003CA2468020A1 Osteopontin-related compositions and methods
06/05/2003CA2467202A1 Expression of polypeptides in rod outer segment membranes
06/05/2003CA2467114A1 A food grade lantibiotic from streptococcus macedonicus and uses thereof
06/05/2003CA2466881A1 Cell culture process
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2466841A1 Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid .beta., prion protein, amylin, .alpha.-synuclein, or polyglutamine repeats for induction of an immune response thereto
06/05/2003CA2466627A1 Chromatographic purification of recombinant human erythropoietin
06/05/2003CA2466478A1 Gene therapy agents for neurodegenerative diseases
06/05/2003CA2466431A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2466298A1 Methods of increasing protein expression levels
06/05/2003CA2464094A1 Methods for ligand discovery
06/05/2003CA2454397A1 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the cns
06/04/2003EP1316612A1 Isozymes of lacrimator component synthase and gene encoding the same
06/04/2003EP1316562A2 Composition comprising a covalent polyethylene glycol (PEG)-protein adduct
06/04/2003EP1316561A1 Fusion protein having enhanced in vivo erythropoietin activity
06/04/2003EP1316560A1 Novel human cancer/testis antigen and gene thereof
06/04/2003EP1316252A1 Disease-resistant plants and method of constructing the same
06/04/2003EP1315974A2 Split-ubiquitin based reporter systems and methods of their use
06/04/2003EP1315970A1 Nucleic acid sequences and proteins involved in cellular senescence
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315963A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315819A2 Nucleotide sequences coding for the chrs gene
06/04/2003EP1315816A2 Genetically engineered co-expression dna vaccines, construction methods and uses thereof
06/04/2003EP1315815A2 Nucleotide sequences which code for the dep34 gene
06/04/2003EP1315814A2 Adhesion molecules
06/04/2003EP1315813A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/04/2003EP1315812A2 Modified polypeptides stabilized in a desired conformation and methods for producing same
06/04/2003EP1315811A2 An iap binding peptide or polypeptide and methods of using the same
06/04/2003EP1315810A2 Family member of inhibitor of apoptosis proteins
06/04/2003EP1315806A1 Method for screening highly active proteases and inhibitors
06/04/2003EP1315805A2 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures
06/04/2003EP1315804A2 Novel mmp-2 derivatives for use as inhibitors of integrin alpha vbeta 3
06/04/2003EP1315802A2 Phenol oxidizing enzyme variants
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315798A2 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof
06/04/2003EP1315795A1 Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production
06/04/2003EP1315794A1 Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315757A2 Process for the purification of epi-hne proteins
06/04/2003EP1315756A2 Electroprocessed fibrin-based matrices and tissues
06/04/2003EP1315755A1 Anti-angiogenic peptides
06/04/2003EP1315754A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/04/2003EP1315753A2 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof
06/04/2003EP1315752A1 Modified proteins, isolated novel peptides, and uses thereof
06/04/2003EP1315751A2 Two receptors of meiosis activating sterols designated sam1a and sam1b
06/04/2003EP1315750A2 Cyclic peptides having melanocortin-4 receptor agonist activity
06/04/2003EP1315749A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport
06/04/2003EP1315748A2 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells
06/04/2003EP1315747A2 Maurotoxin, pi1 and hstx1 derivatives
06/04/2003EP1315746A1 Codon optimised recombinant dermaphagoides allergens
06/04/2003EP1315745A2 Nucleotide sequences which code for the gap2 gene
06/04/2003EP1315743A2 Mammalian genes; related reagents and methods
06/04/2003EP1315742A1 Amino acid substitution mutants of interleukin 13
06/04/2003EP1315740A1 Method for purifying recombinant proteins expressed as insoluble aggregates
06/04/2003EP1315739A2 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof
06/04/2003EP1315738A1 Extended native chemical ligation
06/04/2003EP1315737A1 Orthologues of human receptors and methods of use
06/04/2003EP1315699A2 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
06/04/2003EP1315523A1 Vp22 protein / nucleic acid aggregates, uses thereof
06/04/2003EP1315522A2 Calycins
06/04/2003EP1315517A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
06/04/2003EP1315516A2 Modulation of beta-amyloid levels by beta-secretase bace2
06/04/2003EP1315513A2 "pseudo"-native chemical ligation
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1315511A2 Synthetic erythropoiesis stimulating proteins
06/04/2003EP1315507A2 Hpv-specific short-mers
06/04/2003EP1315431A1 A human gtp-releasing factor family member (15368) and uses therefor
1 ... 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 ... 2916